Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.
about
Antioxidants as potential medical countermeasures for chemical warfare agents and toxic industrial chemicalsDefining cutaneous molecular pathobiology of arsenicals using phenylarsine oxide as a prototypeTopical nitrogen mustard exposure causes systemic toxic effects in mice.Flavanone silibinin treatment attenuates nitrogen mustard-induced toxic effects in mouse skinNitrogen mustard exposure of murine skin induces DNA damage, oxidative stress and activation of MAPK/Akt-AP1 pathway leading to induction of inflammatory and proteolytic mediators.Reactive oxygen species mediate cognitive deficits in experimental temporal lobe epilepsy.Mustard vesicating agent-induced toxicity in the skin tissue and silibinin as a potential countermeasure.Addressing the Symptoms or Fixing the Problem? Developing Countermeasures against Normal Tissue Radiation Injury.Role of oxidative stress in sulfur mustard-induced pulmonary injury and antioxidant protection.Sulfur mustard inhalation: mechanisms of injury, alteration of coagulation, and fibrinolytic therapy.Activation of the chemosensing transient receptor potential channel A1 (TRPA1) by alkylating agents.Scavenging reactive oxygen species inhibits status epilepticus-induced neuroinflammation.From the Cover: Catalytic Antioxidant Rescue of Inhaled Sulfur Mustard Toxicity.Phosgene oxime: Injury and associated mechanisms compared to vesicating agents sulfur mustard and lewisite.Improvements in SOD mimic AEOL-10150, a potent broad-spectrum antioxidant
P2860
Q28601204-737397D6-3423-4B36-9BFF-8AA1E18646EBQ28822278-48946019-5304-4619-B42A-77E52371E9B9Q35019537-B11C11BE-E394-4242-A771-EFCB2FC605DDQ35539206-656689AC-F509-4D83-850F-1DD53FA25E9DQ35602730-B394472B-0B99-425D-8ED7-BEB6EB41F073Q36912566-976D3A98-1193-456D-841D-302CBBCBDDB5Q37083553-882BED5F-DB46-495A-9B8B-755CF9524A2CQ37189966-326C6249-B91D-4BD1-BE39-6C054E2BCB43Q38601927-9075AA45-0B18-488D-8F07-3CF3647F0393Q38888243-FC11E726-D5A5-4BB7-8A86-519206F171FDQ38940552-74B92435-B9EE-45D8-B6E2-6F62E6B410DCQ46318940-60784B30-3D86-4273-A0ED-6107F1A14078Q46492305-96160931-2D40-4197-80D4-80415DBD0A5BQ47710852-949DE280-E8FF-4020-BAF1-9CCC7077E9ADQ58762202-979B7A45-DA9E-494F-91DB-F398A888B976
P2860
Catalytic antioxidant AEOL 10150 treatment ameliorates sulfur mustard analog 2-chloroethyl ethyl sulfide-associated cutaneous toxic effects.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@ast
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@en
type
label
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@ast
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@en
prefLabel
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@ast
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@en
P2093
P2860
P1476
Catalytic antioxidant AEOL 101 ...... iated cutaneous toxic effects.
@en
P2093
Anil K Jain
Brian J Day
Carl W White
Chapla Agarwal
David J Orlicky
Neera Tewari-Singh
Rajesh Agarwal
Swetha Inturi
P2860
P304
P356
10.1016/J.FREERADBIOMED.2014.04.022
P577
2014-05-09T00:00:00Z